Dermatofibroma natural history, complications and prognosis

	Dermatofibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatofibroma natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatofibroma natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dermatofibroma natural history, complications and prognosis
CDC on Dermatofibroma natural history, complications and prognosis
Dermatofibroma natural history, complications and prognosis in the news
Blogs on Dermatofibroma natural history, complications and prognosis
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Dermatofibroma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic.

Common complications of dermatofibroma are related to excisional removing of the lesion and include, bleeding, infection and scar.

Prognosis is generally excellent. Although, in very rare cases metastases are seen.

Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic.^[1]^[2]^[3]

Common complications of dermatofibroma are related to excisional removing of the lesion and include:^[4]
- Bleeding
- Infection
- Scar

Prognosis is generally excellent. Although, in very rare cases metastases are seen.^[5]^[6]

↑ Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). "Phosphohistone-H3 and Ki67". The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
↑ Buehler, Darya; Weisman, Paul (2017). "Soft Tissue Tumors of Uncertain Histogenesis". Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
↑ Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). "A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)". Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
↑ David J.. Myers & Eric P.. Fillman (2019). "Dermatofibroma". PMID 29262213. Unknown parameter |month= ignored (help)
↑ Luzar, BoÅ¡tjan; Calonje, Eduardo (2010). "Cutaneous fibrohistiocytic tumours â an update". Histopathology. 56 (1): 148–165. doi:10.1111/j.1365-2559.2009.03447.x. ISSN 0309-0167. C1 control character in |title= at position 37 (help)
↑ Romano, Ryan C.; Fritchie, Karen J. (2017). "Fibrohistiocytic Tumors". Clinics in Laboratory Medicine. 37 (3): 603–631. doi:10.1016/j.cll.2017.05.007. ISSN 0272-2712.